A revolutionary malaria treatment is to begin trials in Mozambique in healthy people. Along with their standard WHO vaccinations, 2000 newborn infants—and 600 pregnant women—will be given the anti-malarial drug sulfadoxine-pyrimethamine. In a smaller trial in Tanzania, the preventative treatment reduced the rate of clinical malaria by almost 60 per cent, and halved the rate of severe anaemia caused by malaria. Researchers from the Hospital Clinic of Barcelona now hope to confirm these findings.
To continue reading, today with our introductory offers
Advertisement
More from New Scientist
Explore the latest news, articles and features
Humans
Ancient monument may have been an early Stonehenge prototype
News
ÎçÒ¹¸£Àû1000¼¯ºÏ
No young women have died of cervical cancer in England for years
News
ÎçÒ¹¸£Àû1000¼¯ºÏ
Chilling the body with drugs could limit brain damage from stroke
News
Comment
The bigger the lizard, the bigger the Wiki page, discovers ecologist
Regulars
Popular articles
Trending New Scientist articles
1
A quantum state that lasts forever may finally be within our grasp
2
The secrets to keeping your brain sharp in old age
3
Oldest known plague outbreak killed hunter-gatherer children
4
Ancient monument may have been an early Stonehenge prototype
5
Our brains have their first thoughts surprisingly early in life
6
Pigeons lock their eyes in place when they are flying
7
Autism may have two distinct subtypes that vary by brain activity
8
Dinosaur-killing asteroid impact site stayed hot for millions of years
9
Arctic Ocean reaches tipping point that could be dire for marine life
10
Walking shark found in Papua New Guinea is new to science
